{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:04:28Z","timestamp":1761843868650},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T00:00:00Z","timestamp":1227916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s12185-008-0221-1","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T00:40:11Z","timestamp":1227832811000},"page":"471-475","source":"Crossref","is-referenced-by-count":22,"title":["Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy"],"prefix":"10.1007","volume":"88","author":[{"given":"Akihiro","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona H. M.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Y. J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,29]]},"reference":[{"key":"221_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"C Sawyers","year":"2004","unstructured":"Sawyers C. Targeted cancer therapy. Nature. 2004;432:294\u20137.","journal-title":"Nature"},{"key":"221_CR2","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408\u201317.","journal-title":"N Engl J Med"},{"key":"221_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1532\/IJH97.06024","volume":"83","author":"HM Kantarjian","year":"2006","unstructured":"Kantarjian HM, Cortes J. New strategies in chronic myeloid leukemia. Int J Hematol. 2006;83:289\u201393.","journal-title":"Int J Hematol"},{"key":"221_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.exphem.2007.01.023","volume":"35","author":"MW Deininger","year":"2007","unstructured":"Deininger MW. Optimizing therapy of chronic myeloid leukemia. Exp Hematol. 2007;35:144\u201354.","journal-title":"Exp Hematol"},{"key":"221_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc2368","volume":"8","author":"M Savona","year":"2008","unstructured":"Savona M, Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer. 2008;8:341\u201350.","journal-title":"Nat Rev Cancer"},{"key":"221_CR6","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1182\/blood-2004-04-1335","volume":"104","author":"J Cortes","year":"2004","unstructured":"Cortes J, O\u2019Brien S, Kantarjian H. Discontinuation of imatinib therapy after achieving a molecular response. Blood. 2004;104:2204\u20135.","journal-title":"Blood"},{"key":"221_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F Michor","year":"2005","unstructured":"Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL, et al. Dynamics of chronic myeloid leukaemia. Nature. 2005;435:1267\u201370.","journal-title":"Nature"},{"key":"221_CR8","first-page":"979","volume":"90","author":"S Merante","year":"2005","unstructured":"Merante S, Orlandi E, Bernasconi P, Calatroni S, Boni M, Lazzarino M. Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation. Haematologica. 2005;90:979\u201381.","journal-title":"Haematologica"},{"key":"221_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99:319\u201325.","journal-title":"Blood"},{"key":"221_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3816\/CLM.2007.s.005","volume":"7","author":"X Jiang","year":"2007","unstructured":"Jiang X, Smith C, Eaves A, Eaves C. The challenges of targeting chronic myeloid leukemia stem cells. Clin Lymphoma Myeloma. 2007;7:71\u201380.","journal-title":"Clin Lymphoma Myeloma"},{"key":"221_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/CBM-2007-34-503","volume":"3","author":"F Pellicano","year":"2007","unstructured":"Pellicano F, Holyoake TL. Stem cells in chronic myeloid leukaemia. Cancer Biomark. 2007;3:183\u201391.","journal-title":"Cancer Biomark"},{"key":"221_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al. Granulocyte\u2013macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351:657\u201367.","journal-title":"N Engl J Med"},{"key":"221_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nm1487","volume":"12","author":"I Roeder","year":"2006","unstructured":"Roeder I, Horn M, Glauche I, Hochhaus A, Mueller MC, Loeffler M. Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. Nat Med. 2006;12:1181\u20134.","journal-title":"Nat Med"},{"key":"221_CR14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","volume":"108","author":"M Baccarani","year":"2006","unstructured":"Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006;108:1809\u201320.","journal-title":"Blood"},{"key":"221_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.leu.2402392","volume":"16","author":"SE Langabeer","year":"2002","unstructured":"Langabeer SE, Gale RE, Harvey RC, Cook RW, Mackinnon S, Linch DC. Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia. 2002;16:393\u20139.","journal-title":"Leukemia"},{"key":"221_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","volume":"108","author":"T Hughes","year":"2006","unstructured":"Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J, et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood. 2006;108:28\u201337.","journal-title":"Blood"},{"key":"221_CR17","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood-2007-04-038943","volume":"110","author":"JM Goldman","year":"2007","unstructured":"Goldman JM. How I treat chronic myeloid leukemia in the imatinib era. Blood. 2007;110:2828\u201337.","journal-title":"Blood"},{"key":"221_CR18","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1073\/pnas.0601462103","volume":"103","author":"CH Jamieson","year":"2006","unstructured":"Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci USA. 2006;103:6224\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"221_CR19","doi-asserted-by":"publisher","first-page":"11872","DOI":"10.1073\/pnas.172384399","volume":"99","author":"MG Manz","year":"2002","unstructured":"Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA. 2002;99:11872\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"221_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1620\/tjem.210.355","volume":"210","author":"I Ishikawa","year":"2006","unstructured":"Ishikawa I, Kato C, Harigae H, Sugawara T, Tomiya Y, Yamada M, et al. Dose modification of imatinib by monitoring the level of BCR-ABL transcript in chronic myelogenous leukemia. Tohoku J Exp Med. 2006;210:355\u201363.","journal-title":"Tohoku J Exp Med"},{"key":"221_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1365-2141.1999.01749.x","volume":"107","author":"S Branford","year":"1999","unstructured":"Branford S, Hughes TP, Rudzki Z. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. Br J Haematol. 1999;107:587\u201399.","journal-title":"Br J Haematol"},{"key":"221_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.leu.2404549","volume":"21","author":"E Diaz-Blanco","year":"2007","unstructured":"Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494\u2013504.","journal-title":"Leukemia"},{"issue":"Suppl 5","key":"221_CR23","first-page":"65","volume":"7","author":"AC Eaves","year":"1979","unstructured":"Eaves AC, Eaves CJ. Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML). Exp Hematol. 1979;7(Suppl 5):65\u201375.","journal-title":"Exp Hematol"},{"issue":"Suppl 1","key":"221_CR24","first-page":"77","volume":"16","author":"AC Eaves","year":"1998","unstructured":"Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer AL, Eaves CJ. Differences between normal and CML stem cells potential targets for clinical exploitation. Stem Cells. 1998;16(Suppl 1):77\u201383.","journal-title":"Stem Cells"},{"key":"221_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood.V64.1.78.78","volume":"64","author":"AG Leary","year":"1984","unstructured":"Leary AG, Ogawa M. Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells. Blood. 1984;64:78\u201383.","journal-title":"Blood"},{"key":"221_CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1182\/blood.V66.2.312.312","volume":"66","author":"JA Denburg","year":"1985","unstructured":"Denburg JA, Telizyn S, Messner H, Lim B, Jamal N, Ackerman SJ, et al. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood. 1985;66:312\u20138.","journal-title":"Blood"},{"key":"221_CR27","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","volume":"101","author":"R Bhatia","year":"2003","unstructured":"Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL, et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003;101:4701\u20137.","journal-title":"Blood"},{"key":"221_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","volume":"1","author":"R Majeti","year":"2007","unstructured":"Majeti R, Park CY, Weissman IL. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell. 2007;1:635\u201345.","journal-title":"Cell Stem Cell"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0221-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0221-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:53:39Z","timestamp":1589223219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0221-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,29]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0221-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,29]]}}}